$Fastly, Inc.(FSLY)$Care for today mrket. Strong usd after FED yesterday will push alot stock down. Stock like fastly have run from 40-60 almost a 50 % gain in a span of a month.Decent result but not exceptional. Fastly hopefully will be out of loss earning next few season. This mean the company is still burning cash. Market don't look strong as of now. Cheers
$Lucid Group Inc(LCID)$Okay for a start for new investor, before you start chasing high some points to note.- Scaling take time to build infrastructure to scale production.- Right market need right battery chemistry such as why Tesla going LFP etc- Fast charge need right infrastructure such as DC charger, High Capacity AC charger etc etc..- LG chem recent news for GM car recall, battery safety in fast charging and discharge in Lucid- Range depend on battery capacity and electrical motor rating. One could build a 1000miles range if space and capacity allow. Last a good stock dont surge vertical up, institution know before the surge, retailer buy during the surge. Most important dont get stuck high after news is out, play is over. Maybe
$Lucid Group Inc(LCID)$ Got profit please take , next support near 33, if break may touch 30... valuation around 30 at the reasonable level before the next accumulation play
$Lucid Group Inc(LCID)$Lucid is at a market cap higher than nio or xpeng which already been selling 10 of thousand of vehicles and a proprietary network for battery swap and fast charging. For those who know that without a fast charging network, you take hours to charge the batteries even you have the capability of fast charge but the infrastructure is not there to support lucid. It a good concept and design and honestly the range depend on the installed battery capacity to power the vehicle. One could design a 1000miles range car if it could fit but the actual usage would be compromise by the infrastructure available
$Lucid Group Inc(LCID)$care after classic pump and dump.500 plus car delivery and what next after the news. Delivery number is still not impressive so financial result wise is still losing money.Just my 2 cent. The catalyst for the push is the first delivery and how long more to wait for scaling up for next delivery.Of course it still can't compare to tesla now
$AMD(AMD)$ What if AMD, NVIDIA, all follow suit TSMC to increase price on chips.. Well Well, it might be a nice ride up or nice ride downIncrease price also protect revenue and what your thoughts ?
$Moderna, Inc.(MRNA)$How is the small fishes moving along.No current position, just my 2 cent on Moderna. Retracement line in day chart could go lower but rubberband effect still around.
$Moderna, Inc.(MRNA)$For those vested in Moderna, I mentioned not to chased because when selling come, the selling pressure will be high at such a price. Same play for the rest of Biotech stocks that rise on news, revenue and hype. Moderna is a life saving stock, stock with many vaccine in the pipelines but currently only one approved product. If the big fishes are kind enough to push back high, please do a serious reconsideration. It a stock meant for long term play in years to come. Not short term play.Chairman, CEO and others have been constantly selling since last years. The news of share buy back program was meant to buffer when it drop but not to sustain and let the stock hit higher and higher. Institution has been
$Moderna, Inc.(MRNA)$ For those who buy low congrats, for those who have not buy, please don't chase.The higher is goes the greater the seller pressure when it seller come. Don't be the last bag holder. There always demand and supply. Set a stop loss if things goes south. Not a call to buy or sell. Market are forward pricing, guage for yourself if the vaccine could still sell to sustain current price with current PE.
$Moderna, Inc.(MRNA)$For all stock, that being push up. Early investor will take profit during this period. That why early investor cash out since last year. If moderna is good, it will rise slowly day by day not one shot few hundred $ which does not justify the rise.. Dont be a bag holder for biotech stock. Most biotech stock run this way because the route for a successful product is long.